Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness.
about
Evidence-based medical oncology and interventional radiology paradigms for liver-dominant colorectal cancer metastases.The Role of PET Imaging Before, During, and After Percutaneous Hepatic and Pulmonary Tumor AblationMicrowave ablation (MWA) for the treatment of a solitary, chemorefractory testicular cancer liver metastasis.18F-FDG PET/CT Is an Immediate Imaging Biomarker of Treatment Success After Liver Metastasis AblationFeasibility of a Modified Biopsy Needle for Irreversible Electroporation Ablation and Periprocedural Tissue Sampling.Assessing and accounting for the impact of respiratory motion on FDG uptake and viable volume for liver lesions in free-breathing PET using respiration-suspended PET images as referenceC-arm cone-beam computed tomography in interventional oncology: technical aspects and clinical applications.Clinical experience with cone-beam CT navigation for tumor ablation.Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center.Percutaneous radiofrequency ablation for the treatment of hepatocellular carcinoma: long-term follow up, efficacy and prognostic factors.The use of cryoablation in treating liver tumors.Performance of intra-procedural 18-fluorodeoxyglucose PET/CT-guided biopsies for lesions suspected of malignancy but poorly visualized with other modalities.Feasibility of in situ, high-resolution correlation of tracer uptake with histopathology by quantitative autoradiography of biopsy specimens obtained under 18F-FDG PET/CT guidance.Thermal Ablation in the Management of Colorectal Cancer Patients with Oligometastatic Liver Disease.Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome.18F-FDOPA PET/CT-Guided Radiofrequency Ablation of Liver Metastases from Neuroendocrine Tumours: Technical Note on a Preliminary Experience.Ga-68 DOTATOC PET/CT-Guided Biopsy and Cryoablation with Autoradiography of Biopsy Specimen for Treatment of Tumor-Induced Osteomalacia.Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases.AngleNav: MEMS Tracker to Facilitate CT-Guided Puncture.PET/CT-guided interventions: Indications, advantages, disadvantages and the state of the art.18F-FDG PET Biomarkers Help Detect Early Metabolic Response to Irreversible Electroporation and Predict Therapeutic Outcomes in a Rat Liver Tumor Model.Immediate Post-ablation FDG-injection and corresponding Standardized Uptake Value is a Surrogate Biomarker of Local Tumor Progression after Thermal Ablation of Colorectal Carcinoma Liver Metastases.Microwave ablation in combination with chemotherapy for the treatment of advanced non-small cell lung cancer.Interventional Molecular Imaging.Advanced non small cell lung cancer: response to microwave ablation and EGFR Status.Technical Note: Scintillation well counters and particle counting digital autoradiography devices can be used to detect activities associated with genomic profiling adequacy of biopsy specimens obtained after a low activity 18 F-FDG injection.Microwave ablation plus chemotherapy improved progression-free survival of advanced non-small cell lung cancer compared to chemotherapy alone.
P2860
Q26752747-101BD76C-2268-44A5-ABE5-C4E1989384ECQ26830236-44E9954C-0B93-4CE5-AD05-814C52C943EEQ33415967-0561C3ED-6E09-4F49-B01F-8DE4660E53DCQ33835460-A9A819C2-982F-4A4F-9CB3-BFEDF77D3182Q33865049-2D5CD7D8-63F1-4ADF-970C-84B9FEA95B90Q34065472-072B65AF-938B-44BA-BFE6-A8BE964ED543Q34407300-51337A7B-118C-4A5E-A099-FC6B3931DAD3Q35045176-5BC6B7B2-E967-4B76-B1DA-BD322912A126Q36524431-F2E6BA93-70D5-48CE-8BDA-E4AA0EE96F4EQ37647599-FE7243F6-A385-4EAD-A61E-B5A5461F5319Q38168935-B3E64DB0-F766-45B8-B155-4A676F86557CQ38238226-E2F42A07-7EA9-418A-9872-0E9D38C1F487Q38365776-737C6EE9-0E96-4580-9EE1-2DA2AB3F6B2BQ38726773-FD20F944-7773-49F1-8737-7D6C5B8D3D24Q38787064-96D088BD-BD3C-46FF-AA4E-70649112B0B7Q38799074-82CFF2E9-236C-4361-9BEF-D2E778EC338DQ41050767-A0CC9566-A681-4F6C-9E8D-B15CFE337DB7Q42371613-4BAFA7A5-4D87-4CD4-8EBB-B1C6B847FFF5Q47197492-029F867B-8BB9-41B1-9C74-E8FB288B4ECAQ49718900-639EBB1D-1E2F-45F5-962B-8CF454EDD921Q49898099-BA67FFAC-CF85-4363-BC69-2ED1483F901AQ50036604-C0C47747-6C7D-4924-9B2B-7AE7CC9F49C1Q50688576-36855496-97B9-4844-8061-113342AE9100Q51006855-9795E3AE-7BE5-4794-B66E-4C19071FC428Q51630127-4F1491B8-6E47-4550-9AE6-7121ADDA840CQ52685393-6862B9C4-AE78-47F9-BA26-A55B864340B4Q52977202-970E5CD8-0FDA-4569-86F6-FAFA83A0D692
P2860
Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Split-dose technique for FDG P ...... nt of treatment effectiveness.
@en
type
label
Split-dose technique for FDG P ...... nt of treatment effectiveness.
@en
prefLabel
Split-dose technique for FDG P ...... nt of treatment effectiveness.
@en
P2093
P2860
P356
P1433
P1476
Split-dose technique for FDG P ...... nt of treatment effectiveness.
@en
P2093
Constantinos T Sofocleous
E Ronan Ryan
Heiko Schöder
Jorge A Carrasquillo
Joseph P Erinjeri
Raymond Thornton
Robert H Siegelbaum
Sadek Nehmeh
Stephen B Solomon
Steven M Larson
P2860
P304
P356
10.1148/RADIOL.13121462
P407
P577
2013-04-05T00:00:00Z